摘要
目的:评价屋尘螨变应原制剂治疗变应性鼻炎(AR)的临床疗效。方法:采用病例自身对照的方法,通过比较55例AR患者在接受2年的屋尘螨变应原制剂特异性免疫治疗前后的症状、体征积分,观察该制剂的临床疗效。结果:55例患者在完成特异性免疫治疗后的症状、体征积分较治疗前均明显减少,差异具有统计学意义(P<0.01)。结论:屋尘螨变应原制剂是治疗尘螨引起的AR的一种有效治疗方法。
Objective：To evaluate the efficacy of specific immunotherapy（SIT） with standardized house dust mite allergen preparation for allergic rhinitis（AR）.Method：Fifty-five patients with allergic rhinitis caused by house dust mites were selected in this self-control study.Clinical efficacy was evaluated by symptom and sign score after two years of specific immunotherapy and compared with pre-treatment scores.Result：After completing the study,a clinically significant reduction in symptom and sign score in these patients was noted,compared with that of pre-treatment.And the difference was statistically significant（P0.01）.Conclusion：Standardized house dust mite allergen preparation is an effective treatment in patients suffering from allergic rhinitis due to house dust mites.
出处
《临床耳鼻咽喉头颈外科杂志》
CAS
CSCD
北大核心
2012年第11期487-489,共3页
Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词
鼻炎
变应性
常年性
屋尘螨
变应原制剂
rhinitis
allergic
perennial
house dust mite
allergen preparation
